OTC:KOAN
Resonate Blends, Inc.
A niche OTC specialty manufacturer providing custom fragrance and flavor blends to help brands differentiate their personal care and cosmetic products.
Key Metrics
Investment Thesis
Bull Case
KOAN offers speculative upside potential for investors willing to bet on a turnaround story in the growing global fragrance market valued at billions. The company's specialized blending capabilities could capture significant market share if it can stabilize operations and attract new distribution partners in 2025. Current low market capitalization provides a high reward-to-risk ratio for early-stage investors who believe in the management team's ability to execute a restructuring plan.
Bear Case
The stock carries extreme risk due to negative shareholders' equity of $3.2M and a retained earnings deficit that exceeds three times the company's total assets. Negative cash flow from operations combined with significant investing outflows suggests the company is burning through capital without a clear path to profitability. Investors should avoid this position as the lack of revenue in 2022-2023 followed by recent losses indicates fundamental business model issues that have not yet been resolved.
About Resonate Blends, Inc.
Resonate Blends, Inc. (KOAN) operates as a specialty blending company focused on creating customized fragrance and flavor solutions for niche markets including cosmetics, personal care, and industrial applications. The company leverages its proprietary blend technologies to serve clients seeking unique olfactory profiles that differentiate their consumer products in competitive retail environments.
Analysis
Management Discussion
The company's financial performance deteriorated significantly in 2024 with a net loss widening to $2.1M compared to -$1.4M the prior year, despite total assets remaining flat at $1.9M. Operating expenses surged to $2.9M against only $1.9M in revenue, resulting in an operating profit margin of -89% and a severe cash burn rate that depleted liquidity reserves. The company's ability to service its current liabilities of $5.1M is critically impaired by the combination of negative retained earnings and minimal operating cash generation.
Industry Overview
The global fragrance and flavor ingredients market is expanding as consumer demand for personalized and sustainable products increases, creating opportunities for specialized blenders. However, the industry is highly competitive with established giants controlling major supply chains, making it difficult for small players to achieve economies of scale without significant capital investment. Regulatory compliance regarding ingredient safety remains a constant operational challenge that can impact margins if not managed proactively.
Financial Statements
Income Statement
Balance Sheet
Cash Flow
| Metric | 2022 | 2023 | 2024 |
|---|---|---|---|
| Revenue | $49.5K | $16.5K | $1.9M |
| Cost of Revenue | $33.1K | $114.1K | $660.0K |
| Gross Profit | $16.4K | $-97.7K | $1.2M |
| Operating Expenses | $1.4M | $301.6K | $2.9M |
| Operating Income | $-1.4M | $-399.2K | $-1.7M |
| R&D | — | — | $61.9K |
| G&A | $191.7K | $163.9K | $1.2M |
| Stock-Based Comp | $211.0K | — | — |
| D&A | $7.7K | — | $17.1K |
| Depreciation | $7.7K | — | — |
| Other OpEx | $1.2M | $137.6K | $1.7M |
| Non-Operating Income | $0 | $0 | $0 |
| Pre-Tax Income | $-1.4M | $-399.2K | $-1.7M |
| Income Tax | $-2.0M | $1.0M | $435.6K |
| Continuing Ops | $653.6K | $-1.4M | $-2.1M |
| Discontinued Ops | $0 | $0 | $0 |
| Net Income | $653.6K | $-1.4M | $-2.1M |
| Minority Interest | $0 | $0 | $0 |
| Net to Common | $653.6K | $-1.4M | $-2.1M |
| Metric | 2022 | 2023 | 2024 |
|---|---|---|---|
| Current Assets | $374.9K | $976.9K | $1.0M |
| Cash & Equivalents | $64.4K | $6.9K | $8.0K |
| Accounts Receivable | — | — | $49.7K |
| Inventory | $160.5K | — | — |
| Other Current Assets | $150.0K | $970.0K | $976.0K |
| Long-Term Assets | $24.2K | $15.4K | $820.7K |
| PP&E (Net) | $24.1K | $15.3K | $15.3K |
| Other LT Assets | $0 | $0 | $0 |
| Total Assets | $399.1K | $992.3K | $1.9M |
| Current Liabilities | $1.5M | $3.1M | $5.1M |
| Long-Term Liabilities | $0 | $0 | $0 |
| Total Liabilities | $1.5M | $3.1M | $5.1M |
| Shareholders' Equity | $-1.1M | $-2.1M | $-3.2M |
| Paid-In Capital | $24.4M | $24.9M | $25.5M |
| Retained Earnings | $-25.3M | $-26.7M | $-28.9M |
| Total L&E | $399.1K | $992.3K | $1.9M |
| Metric | 2022 | 2023 | 2024 |
|---|---|---|---|
| Net Income (CFO) | $653.6K | $-1.4M | $-2.1M |
| Non-Cash Adjustments | $-2.4M | $1.2M | $346.8K |
| Working Capital Changes | $286.1K | $265.2K | $757.3K |
| Cash from Operations | $-1.4M | $11.2K | $-1.0M |
| Cash from Investing | $0 | $-805.0K | $-358.3K |
| Cash from Financing | $1.5M | $736.4K | $1.4M |
| FX Effect | $0 | $0 | $0 |
| Net Change in Cash | $51.5K | $-57.5K | $1.1K |
| Beginning Cash | $12.9K | $64.4K | $6.9K |
| Ending Cash | $64.4K | $6.9K | $8.0K |
Frequently Asked Questions
How does Resonate Blends, Inc. make money?
Primary revenue streams include custom fragrance development for cosmetics, bulk flavor blending for food and beverage clients, and specialized industrial solvent mixtures. Additional segments may include licensing proprietary scent technologies and direct-to-consumer premium blend kits for small business entrepreneurs.
What are the main risks for KOAN?
Severe liquidity crisis indicated by negative working capital of -$4.1M and a retained earnings deficit of $28.9M threatens operational continuity. Negative cash flow from operations of $1.0M suggests the business model struggles to generate organic liquidity without external financing. High concentration risk exists as revenue only materialized in 2024 after two years of zero revenue, indicating potential market instability.
What is KOAN's competitive advantage?
Proprietary formulation chemistry allows for exclusive scent profiles not available from major competitors, creating high switching costs for clients. Niche focus on small-batch customization enables rapid prototyping that large conglomerates cannot match efficiently. Strong relationships with independent cosmetic manufacturers seeking to avoid generic 'off-the-shelf' ingredients.
Related Companies
Not financial advice. All content is for informational purposes only. Data may contain errors. Consult a qualified financial advisor before making investment decisions.